Clinical and Mutational Spectrum of Neurofibromatosis Type 1-Like Syndrome
JAMA 302:2111-2118, 2150, 2170, Messian,L.,et al, 2009
Duchenne Muscular Dystrophy
BMJ 368:L7012, Fox, H.,et al, 2020
Learning Disability
Lancet 362:811-821, Gillberg,C.&Soderstrom,H., 2003
Cognitive Function and Academic Performance in Neurofibromatosis 1:North
K. N. , et al, Neurol 48:1121-11277., , 1997
Advances in Molecular Analysis of Fragile X Syndrome
552, Warren,W.T.&Nelson,D.L.JAMA 271:536-553, 1994
Neurofibromatosis Type 1:The Cognitive Phenotype
J Pediatr 124:S1-S8, Hofman,K.J.,et al, 1994
Specific Learning Disability in Children with Neurofibromatosis Type 1:Significance of MRI Abnormalities
Neurol 44:878-883, North,K.,et al, 1994
Girls with Fragile X Syndrome:Physical and Neurocognitive Status and Outcome
Pediatrics 89:395-400, Hagerman,R.J.,et al, 1992
Tourette Syndrome and Other Tic Disorders, Diagnosis, Pathophysiology, and Treatment
Medicine 70:15-32, Singer,H.S.&Walkup,J.T., 1991
Mental Retardation in Turner Syndrome
J Pediatr 118:415-417, VanDyke,D.L.,et al, 1991
Neurofibromatosis Type 1 (Recklinghausen's Disease) , Neurologic and Cognitive Assessment
Am J Dis Child 143:833-837, Eldridge,R.,et al, 1989
Treating Problem Children with Stimulant Drugs
NEJM 289:407, Sroufe,L.A.,et al, 1973